These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 38726682)
1. Prognostic relevance of circulating lymphoma cells at diagnosis in newly diagnosed follicular lymphoma patients. Annunzio K; Bhatta S; Hanel W; Zhao Q; Owen M; Rosen H; Voorhees TJ; Bond DA; Sawalha Y; Sigmund AM; Alinari L; Baiocchi RA; Maddocks KJ; Jones D; Christian B; Epperla N Hematol Oncol; 2024 May; 42(3):e3278. PubMed ID: 38726682 [TBL] [Abstract][Full Text] [Related]
2. [The clinical features, survival analysis, and geriatric assessment of 85 patients with follicular lymphoma: a single-center study]. Yin JJ; Qian L; Bai JF; Feng R; Li JT; Wang T; Zhang CL; Liu H Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):233-241. PubMed ID: 38716594 [No Abstract] [Full Text] [Related]
4. [Clinical features and outcomes of newly diagnosed follicular lymphoma concurrent with diffuse large B-cell lymphoma component]. Lin ZJ; Zha J; Yi SH; Li ZF; Ping LY; He XH; Yu HF; Zheng Z; Xu W; Chen FL; Xie Y; Chen BY; Zhang HL; Wang L; Ding KY; Li WY; Yang HY; Zhao WL; Qiu LG; Li ZM; Song YQ; Xu B Zhonghua Xue Ye Xue Za Zhi; 2022 Jun; 43(6):456-462. PubMed ID: 35968587 [No Abstract] [Full Text] [Related]
5. Progression of disease within 2 years (POD24) is a clinically relevant endpoint to identify high-risk follicular lymphoma patients in real life. Sortais C; Lok A; Tessoulin B; Gastinne T; Mahé B; Dubruille V; Blin N; Touzeau C; Moreau A; Bossard C; Peterlin P; Garnier A; Guillaume T; Le Bourgeois A; Chevallier P; Moreau P; Leux C; Le Gouill S Ann Hematol; 2020 Jul; 99(7):1595-1604. PubMed ID: 32417940 [TBL] [Abstract][Full Text] [Related]
6. Rituximab and Chemotherapy for Newly Diagnosed Follicular Lymphoma: Real-World Report of Polish Lymphoma Research Group. Paszkiewicz-Kozik E; Debowska M; Jakacka N; Kotarska M; Szymanski M; Wisniewski K; Konska A; Jarzembowska M; Drozd-Sokolowska J; Romejko-Jarosinska J; Szumera-Cieckiewicz A; Rymkiewicz G; Ziarkiewicz-Wroblewska B; Lech-Maranda E; Walewski J; Hus I Chemotherapy; 2022; 67(4):201-210. PubMed ID: 35249035 [TBL] [Abstract][Full Text] [Related]
7. Follicular Lymphoma in Chile in the Adult Public Cancer Program: The Impact of Chemoimmunotherapy. Cabrera ME; Peña C; Vega V; Rojas H; Pizarro A; Rojas C; Calderon S; Oliva J; Hales C; Rojas B; Intriago M; Capurro M; Gonzalez ML; Castillo JJ Cancer Rep (Hoboken); 2024 Sep; 7(9):e2126. PubMed ID: 39307921 [TBL] [Abstract][Full Text] [Related]
8. [Clinical Features of Diffuse Large B-Cell Lymphoma Transformed from Follicular Lymphoma]. Zhang XL; Yu WJ; Zhu YN; Yang CM; Xiao F; Mai WY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1772-1778. PubMed ID: 36476902 [TBL] [Abstract][Full Text] [Related]
9. Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study†. Casulo C; Day B; Dawson KL; Zhou X; Flowers CR; Farber CM; Hainsworth JD; Cerhan JR; Link BK; Zelenetz AD; Friedberg JW Ann Oncol; 2015 Nov; 26(11):2311-7. PubMed ID: 26362568 [TBL] [Abstract][Full Text] [Related]
10. [Leukemization of follicular lymphoma: The features of diagnostic and clinical course of a rare form of the disease]. Nesterova ES; Kravchenko SK; Mangasarova YK; Plastinina LV; Dvirnyk VN; Kovrigina AM; Shchupletsova IA; Obukhova TN; Gemdzhian EG; Vorobyev IA; Vorobyev AI Ter Arkh; 2017; 89(7):45-50. PubMed ID: 28766540 [TBL] [Abstract][Full Text] [Related]
11. [Clinical Features, Treatment and Prognostic Factors of 94 Patients with Follicular Lymphoma]. DU XY; Hu K; Zhao W; Yang P; Wan W; Jing HM; Ke XY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):756-764. PubMed ID: 29950216 [TBL] [Abstract][Full Text] [Related]
12. Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up analysis of the JCOG0203 trial. Watanabe T; Tobinai K; Wakabayashi M; Morishima Y; Kobayashi H; Kinoshita T; Suzuki T; Yamaguchi M; Ando K; Ogura M; Taniwaki M; Uike N; Yoshino T; Nawano S; Terauchi T; Hotta T; Nagai H; Tsukasaki K; Lancet Haematol; 2018 Nov; 5(11):e520-e531. PubMed ID: 30389034 [TBL] [Abstract][Full Text] [Related]
13. Impact of circulating lymphoma cells at diagnosis on outcomes in patients with Waldenstrom macroglobulinemia. Nalin A; Zhao Q; Voorhees T; Bond D; Sawalha Y; Hanel W; Sigmund A; Annunzio K; Alinari L; Baiocchi R; Maddocks K; Jones D; Christian B; Epperla N Front Oncol; 2023; 13():1264387. PubMed ID: 37781209 [TBL] [Abstract][Full Text] [Related]
14. Low absolute lymphocyte count is a poor prognostic factor for untreated advanced follicular lymphoma treated with rituximab plus bendamustine: results of the prospective phase 2 CONVERT trial. Rai S; Inoue H; Hanamoto H; Matsuda M; Maeda Y; Wada Y; Haeno T; Watatani Y; Kumode T; Hirase C; Espinoza JL; Morita Y; Tanaka H; Tatsumi Y; Matsumura I Int J Hematol; 2021 Aug; 114(2):205-216. PubMed ID: 33864623 [TBL] [Abstract][Full Text] [Related]
15. Peripheral blood lymphocyte/monocyte ratio predicts outcome in follicular lymphoma and in diffuse large B-cell lymphoma patients in the rituximab era. Belotti A; Doni E; Bolis S; Rossini F; Casaroli I; Pezzatti S; Pogliani EM; Pioltelli PE Clin Lymphoma Myeloma Leuk; 2015 Apr; 15(4):208-13. PubMed ID: 25468321 [TBL] [Abstract][Full Text] [Related]
16. Early histological transformation of follicular lymphoma to diffuse large B-cell lymphoma indicating adverse survival: A population-based analysis and validation. Li ZH; Zhang MY; Federico M; Civallero M; Manni M; Alonso-Alvarez S; Hou J; Huang HH Cancer; 2024 Oct; 130(19):3321-3332. PubMed ID: 38809573 [TBL] [Abstract][Full Text] [Related]
17. CD5-positive follicular lymphoma: clinicopathologic correlations and outcome in 88 cases. Li Y; Hu S; Zuo Z; Hong M; Lin P; Li S; Konoplev S; Wang Z; Khoury JD; Young KH; Medeiros LJ; Yin CC Mod Pathol; 2015 Jun; 28(6):787-98. PubMed ID: 25743023 [TBL] [Abstract][Full Text] [Related]
18. Clinicobiological features and prognostic impact of diffuse large B-cell lymphoma component in the outcome of patients with previously untreated follicular lymphoma. Magnano L; Balagué O; Dlouhy I; Rovira J; Karube K; Pinyol M; Rivas-Delgado A; Costa D; Martínez-Trillos A; González-Farre B; Martínez-Pozo A; Giné E; Colomer D; Delgado J; Villamor N; Campo E; López-Guillermo A Ann Oncol; 2017 Nov; 28(11):2799-2805. PubMed ID: 29045517 [TBL] [Abstract][Full Text] [Related]
19. Early progression in follicular lymphoma in the absence of histological transformation or high-risk Follicular Lymphoma International Prognostic Index still has a favourable outcome. Muntañola A; Mozas P; Mercadal S; Huguet M; Bobillo S; Bastos-Oreiro M; Jiménez-Ubieto A; Rovira J; Rivero A; Tolosa C; Luizaga L; de Villambrosia SG; Novelli S; Caballero D; Salar A; Alonso-Álvarez S; Magnano L; Gutiérrez NC; Sancho JM; López-Guillermo A; Br J Haematol; 2023 Feb; 200(3):306-314. PubMed ID: 36261137 [TBL] [Abstract][Full Text] [Related]
20. Clinical features of de novo CD25-positive follicular lymphoma. Fujiwara S; Muroi K; Tatara R; Matsuyama T; Ohmine K; Suzuki T; Mori M; Nagai T; Tanaka A; Ozawa K Leuk Lymphoma; 2014 Feb; 55(2):307-13. PubMed ID: 23697843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]